We recently published a list of 10 Biggest Gainers of Last Week. In this article, we are going to take a look at where Teva ...

TEVAN.UL] failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ...

Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1% higher at $22.42 on Tuesday. The Israeli drugmaker stock added 34.5% in the preceding six sessions ...

Wall Street experienced a positive start to the Santa Rally season, with all major indices and sectors closing higher in the ...

TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 43 rd ...

Bearish flow noted in Teva (TEVA) with 37,689 puts trading, or 3x expected. Most active are Mar-25 12 puts and Mar-25 15 puts, with total ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) saw some unusual options trading activity on Monday.

Teva Pharmaceuticals is one of the best performing stocks in the SPDR S&P Pharmaceuticals ETF ( XPH) for 2024 as the stock ...

As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...

When Investors Make Decisions in Teva Pharmaceutical Industries Limited American Depositary Shares TEVA Opportunities Surface ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ...

The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group. A group of patients with ...